Cognitive ⏱ Half-life: Short — typical of small peptide bioregulators. Experimental

Cerluten

Cerluten (Brain Peptide Bioregulator)

Evidence at a Glance

Regulatory statusExperimental
Khavinson CNS/brain peptide extract; registered in Russia as a bioregulator/supplement, no FDA/EMA approval; sold elsewhere as a research chemical.
Human evidenceAnecdotal only
Animal evidenceLimited

Human claims rest on uncontrolled Russian/vendor reports rather than independent randomized trials, and the peptide has no approval outside its bioregulator registration in Russia.

What the research does not support

  • It is not approved by the FDA or EMA and is sold only as a research chemical.
  • No independent, peer-reviewed randomized trials demonstrate any clinical benefit.
  • It has not been shown to restore vision or reverse retinal disease in controlled studies.
  • It is not a proven anti-aging or brain-repair therapy in humans.
Half-Life
Short — typical of small peptide bioregulators.
Mol. Weight
Peptide complex

What is Cerluten?

Cerluten is a brain-targeting peptide bioregulator designed to support CNS tissue function through epigenetic modulation of neuronal gene expression. It represents the Khavinson approach to neuroprotection — using tissue-specific short peptides to restore youthful gene expression patterns.

Research Applications

Cognitive aging, neuroprotection, post-stroke recovery support, neurodegenerative disease models, and CNS tissue maintenance.

Dosage Information (Research Use)

Oral capsules: 1-2 capsules daily for 10-30 day courses. Injectable: 10 mg/day for 10-day courses. Research use only.

Reconstitution & Handling

Capsules taken orally. Injectable form: standard BAC water reconstitution.

Half-Life & Pharmacokinetics

Short — typical of small peptide bioregulators.

Reported Observations in Literature

Generally well-tolerated in published research. No significant adverse effects reported.

Key Research References

  • Khavinson VK. “Peptide regulation of gene expression and protein synthesis in aging.” Bull Exp Biol Med. 2007

How Cerluten Works

Cerluten is a peptide bioregulator derived from brain tissue extracts, designed to modulate gene expression in central nervous system cells. It targets neuronal resilience pathways, antioxidant defense mechanisms, and neurotransmitter balance maintenance. Like other Khavinson bioregulators, it works at the epigenetic level to normalize tissue-specific gene expression.

Research Findings

Part of the Russian peptide bioregulator tradition. Studied for age-related cognitive decline, post-stroke recovery support, and neurodegenerative condition models. Available in oral capsule form in some markets.

Dosage & Administration

Oral capsules: 1-2 capsules daily for 10-30 day courses. Injectable: 10 mg/day for 10-day courses. Research use only.

Safety & Side Effects

Generally well-tolerated in published research. No significant adverse effects reported.

Important: All safety information is derived from published research, primarily animal studies. No controlled human clinical trial data exists unless explicitly noted. This compound is sold for research purposes only.

Quick Facts

Sequence Short peptide bioregulator complex targeting CNS tissue
Molecular Weight Peptide complex
Half-Life Short — typical of small peptide bioregulators.
Available Sizes 5mg, capsules
Storage Room temperature for capsules. Lyophilized: -20°C.

Key Research References

  • Khavinson VK. "Peptide regulation of gene expression and protein synthesis in aging." Bull Exp Biol Med. 2007

Related Peptides

View all →
P21
Cognitive
CNTF-derived tetrapeptide researched for neurogenesis, cognitive enhancement, and neurodegenerative disease models.
Cognitive
One of the most abundant brain signaling molecules — regulates appetite, stress response, anxiety, and circadian rhythms.
Cognitive
Synthetic analog of tuftsin researched for anxiolytic, nootropic, and immunomodulatory properties without sedative effects.